相似文献
1
Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma.
NPJ Prim Care Respir Med. 2014 Jun 26;24:14019. doi: 10.1038/npjpcrm.2014.19.
2
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
NPJ Prim Care Respir Med. 2016 Nov 24;26:16079. doi: 10.1038/npjpcrm.2016.79.
3
[A STUDY OF INSPIRATORY RESISTANCE OF DRY POWDER INHALER OF AGENTS FOR ASTHMA CONTROL].
Arerugi. 2016 Jul;65(7):932-6. doi: 10.15036/arerugi.65.932.
4
[Asthma inhaler with feedback system provided better care and lower costs].
Lakartidningen. 2014;111(5):160.
5
Dry-powder inhalers in acute asthma.
Ther Deliv. 2014 Jan;5(1):69-81. doi: 10.4155/tde.13.132.
6
Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
Int J Pharm. 2016 Jul 25;509(1-2):50-58. doi: 10.1016/j.ijpharm.2016.05.023. Epub 2016 May 18.
7
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
BMC Pulm Med. 2013 Dec 7;13:72. doi: 10.1186/1471-2466-13-72.
8
Inhaler technique maintenance: gaining an understanding from the patient's perspective.
J Asthma. 2011 Aug;48(6):616-24. doi: 10.3109/02770903.2011.580032. Epub 2011 May 31.
9
[New dry powder inhalers].
Pneumonol Alergol Pol. 2015;83(1):83-7. doi: 10.5603/PiAP.2015.0012.
10
Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study.
Expert Opin Drug Deliv. 2014 Dec;11(12):1849-57. doi: 10.1517/17425247.2014.949236. Epub 2014 Aug 23.
引用本文的文献
1
A Multi-Mode Education Program to Enhance Asthma Care by Pharmacists.
Am J Pharm Educ. 2022 Apr;86(4):8633. doi: 10.5688/ajpe8633. Epub 2021 Aug 16.
2
The evaluation of the correct use and ease-of use of the ELLIPTA DPI in children with asthma.
Pediatr Pulmonol. 2021 Jan;56(1):57-64. doi: 10.1002/ppul.25149. Epub 2020 Nov 19.
3
Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study).
J Thorac Dis. 2020 May;12(5):1877-1883. doi: 10.21037/jtd-19-3913.
4
Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease.
Pulm Ther. 2017 Dec;3(2):267-281. doi: 10.1007/s41030-017-0046-2. Epub 2017 Jun 27.
5
Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management.
Pulm Ther. 2018 Jun;4(1):1-12. doi: 10.1007/s41030-018-0051-0. Epub 2018 Apr 5.
6
Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease.
Chron Respir Dis. 2019 Jan-Dec;16:1479973118815692. doi: 10.1177/1479973118815692.
7
Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthma.
Patient Prefer Adherence. 2016 May 13;10:825-36. doi: 10.2147/PPA.S83946. eCollection 2016.
8
Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis.
Drugs. 2016 Mar;76(3):343-61. doi: 10.1007/s40265-015-0532-5.
9
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):486-97. doi: 10.1089/jamp.2015.1224. Epub 2015 Sep 15.
10
In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):498-506. doi: 10.1089/jamp.2015.1225. Epub 2015 Sep 15.
本文引用的文献
1
Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):553-61. doi: 10.1016/j.jaip.2014.02.010. Epub 2014 Apr 24.
2
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
BMC Pulm Med. 2014 Jul 9;14:113. doi: 10.1186/1471-2466-14-113.
3
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
BMC Pulm Med. 2013 Dec 7;13:72. doi: 10.1186/1471-2466-13-72.
4
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
Eur Respir J. 2014 Mar;43(3):773-82. doi: 10.1183/09031936.00064513. Epub 2013 Oct 17.
5
Inhaler competence in asthma: common errors, barriers to use and recommended solutions.
Respir Med. 2013 Jan;107(1):37-46. doi: 10.1016/j.rmed.2012.09.017. Epub 2012 Oct 23.
6
Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthma.
Prim Care Respir J. 2011 Jun;20(2):148-54. doi: 10.4104/pcrj.2011.00022.
7
A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
J Asthma. 1998;35(4):337-45. doi: 10.3109/02770909809075666.
8
Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study.
Fam Pract. 1996 Feb;13(1):35-40. doi: 10.1093/fampra/13.1.35.
9
Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group.
J Asthma. 1995;32(6):429-36. doi: 10.3109/02770909409077754.
Zotero 插件